Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
2016 · Clinical Cancer Research · 819 citations
https://doi.org/10.1158/1078-0432.ccr-15-2878
E
Ellen Stelloo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
4.2K
Citations
25
h-index
33
i10-index
Ellen Stelloo is an academic researcher from Cergentis (Netherlands). The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Cancer Genomics and Diagnostics. The author has an h-index of 25, co-authored 104 publications.
ORCID: 0000-0002-1264-3594Papers by this author
worksPatient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses
2020 · Cell Reports · 284 citations
https://doi.org/10.1016/j.celrep.2020.107762
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
2018 · British Journal of Cancer · 269 citations
https://doi.org/10.1038/s41416-018-0310-8
Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
2020 · Cancer Immunology Research · 81 citations
https://doi.org/10.1158/2326-6066.cir-20-0149
Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns
2021 · Nature Genetics · 68 citations
https://doi.org/10.1038/s41588-021-00891-2
Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup
2020 · Cancers · 48 citations
https://doi.org/10.3390/cancers12051308
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat